A discovery by Melbourne researchers could help to identify patients with a particularly aggressive type of lung cancer that are likely to respond to immunotherapies currently used in the clinic to treat other cancers.
Mar 8, 2018
0
42
While studying the underpinnings of multiple sclerosis, investigators at Brigham and Women's Hospital came across important clues for how to treat a very different disease: cancer. In a paper published in Science Immunology, ...
May 19, 2017
0
1907
This week, scientists from the A·WOL Consortium based at the Liverpool School of Tropical Medicine have published a paper entitled 'Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes ...
Mar 16, 2017
0
0
Scientists have significantly improved their understanding of cancer and have developed numerous therapies that have helped to reduce patient mortality; however, the majority of drugs that make it to the clinical trial phase ...
Nov 10, 2016
0
0
A mouse model predicted that inhibition of the enzyme MEK using targeted therapy may provide an effective, single-agent treatment for pediatric patients with neurofibroma, and early results from a phase I trial support this ...
Nov 5, 2013
0
0
(Medical Xpress)—Researchers at the University of Virginia School of Medicine have developed a promising new antibiotic to treat potentially deadly gastrointestinal infections without harming the beneficial probiotic bacteria ...
Apr 12, 2013
0
0
(Medical Xpress)—Some 500,000 people die of cancer in the United States each year, often because their cancers have become resistant to approved therapies. Scientists at Roswell Park Cancer Institute (RPCI) have made headway ...
Sep 21, 2012
0
0
Clinical trials start this week for a stroke drug initially created by a team led by scientists at The Scripps Research Institute and the University of Southern California (USC), and further developed by biotech company ZZ ...
Aug 8, 2012
0
0
Autism Speaks, the world's leading autism science and advocacy organization, today announced its expanded collaboration with Sigma Advanced Genetic Engineering (SAGE) Labs, an initiative of Sigma Life, to develop the first ...
Aug 2, 2012
0
0
Findings from preclinical studies in a skin cancer model showed that next-generation BRAF inhibitors used alone, or first-generation BRAF inhibitors used in combination with an epidermal growth factor receptor inhibitor, ...
Nov 13, 2011
0
0
